- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 1, 2024 | 224.34M sh |
| Capex | Q3 2024 · Sep 30, 2024 | $945K |
| Capex | Q3 2024 · Sep 30, 2023 | $16.3M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $5.28B |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $5.23B |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $1.09B |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $1.49B |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $15.07B |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $13.54B |
| Current Assets | Q3 2024 · Sep 30, 2024 | $1.6B |
| Current Assets | Q3 2024 · Dec 31, 2023 | $1.88B |
| Total Assets | Q3 2024 · Sep 30, 2024 | $22.1B |
| Total Assets | Q3 2024 · Dec 31, 2023 | $20.45B |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 217.34M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 216.03M sh |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$704.73M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$4.92 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$5.81 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$4.92 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$5.81 |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $53.25M |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $163.96M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $5.04M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $14.15M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$1.07B |
| Net Income | Q3 2024 · Sep 30, 2023 | −$1.25B |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$1.35B |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$1.78B |
| Revenue | Q3 2024 · Sep 30, 2023 | $563.18M |
| Revenue | Q3 2024 · Sep 30, 2023 | $1.74B |